Chordia Therapeutics Inc Revenue

Biotechnology Research • Fujisawa City, Kanagawa, Japan • 11-20 Employees

Chordia Therapeutics Inc revenue & valuation

Annual revenue	$1,026,660
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$3,300,000
Total funding	$26,900,000

Key Contacts at Chordia Therapeutics Inc

Robert Oda

Senior Director - Medical Science

Eiji Takahara

Senior Director

Company overview

Headquarters	26-1 Muraokahigashi 2-chome, Fujisawa, Kanagawa 251-0012, JP
Website	chordiatherapeutics.com
NAICS	541714
Keywords	AML, Biotech, Clinical, Oncology, MDS, Pharceutical
Founded	2017
Employees	11-20
Socials

Chordia Therapeutics Inc Email Formats

Chordia Therapeutics Inc uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@chordiatherapeutics.com), used 85.7% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@chordiatherapeutics.com	85.7%
{first name}.{last name}	john.doe@chordiatherapeutics.com	14.3%

About Chordia Therapeutics Inc

Chordia Therapeutics is a clinical-stage biotech company engaged in the research and development of novel therapies for cancers with high unmet medical needs. The Company was spun out from Takeda Pharmaceutical in November 2017.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

C-Suite

Director

Head

Employees by Department

Chordia Therapeutics Inc has 4 employees across 4 departments.

Departments

Number of employees

Funding Data

Explore Chordia Therapeutics Inc's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2019-05-01	5	$26,900,000

Funding Insights

$26,900,000

Total funding amount

$26,900,000

Most recent funding amount

Number of funding rounds

Frequently asked questions

Chordia Therapeutics Inc is located in Fujisawa City, Kanagawa, JP.

Chordia Therapeutics Inc generates an estimated annual revenue of $1,026,660. This revenue figure reflects the company's market position and business performance in its industry.

Chordia Therapeutics Inc has an estimated valuation of $3,300,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Chordia Therapeutics Inc was founded in 2017, making it 9 years old. The company has established itself as a significant player in its industry over this time.

Chordia Therapeutics Inc has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Chordia Therapeutics Inc has raised a total of $26,900,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Chordia Therapeutics Inc

Robert Oda

Senior Director - Medical Science

Eiji Takahara

Senior Director

4.8

40,000 users